2023 - Research.com Medicine in France Leader Award
2023 - Research.com Genetics in France Leader Award
2012 - Member of Academia Europaea
Member of the European Molecular Biology Organization (EMBO)
His main research concerns Cancer research, Genetics, Pathology, Gene and Molecular biology. His Cancer research study integrates concerns from other disciplines, such as Mutation, Germline mutation, Germline, Sarcoma and Neuroblastoma. His study in Neuroblastoma is interdisciplinary in nature, drawing from both Gene duplication, Regulation of gene expression and Immunology.
His Pathology research includes elements of Cancer, Internal medicine, Proportional hazards model, Oncology and Comparative genomic hybridization. His research integrates issues of Immunohistochemistry and Medulloblastoma in his study of Cancer. The Molecular biology study combines topics in areas such as Cellular differentiation, Gene expression profiling, Chromosomal translocation, Chromosome and Transcription.
His primary areas of investigation include Cancer research, Genetics, Pathology, Molecular biology and Neuroblastoma. Olivier Delattre interconnects Carcinogenesis, Cancer, Transcription factor and Sarcoma in the investigation of issues within Cancer research. All of his Genetics and Gene, Chromosome 22, Chromosome, Gene mapping and Locus investigations are sub-components of the entire Genetics study.
The concepts of his Pathology study are interwoven with issues in Internal medicine, Comparative genomic hybridization, Oncology and Gene expression profiling. His Molecular biology study combines topics from a wide range of disciplines, such as Fluorescence in situ hybridization and Chromosomal translocation. His Neuroblastoma study frequently involves adjacent topics like Stage.
Olivier Delattre mainly investigates Cancer research, Sarcoma, Carcinogenesis, Neuroblastoma and Cancer. His work deals with themes such as Transcription factor, Immune system, Immunotherapy, SMARCB1 and Pediatric cancer, which intersect with Cancer research. His Pediatric cancer research is within the category of Genetics.
His Sarcoma research incorporates elements of Fusion gene, Transcriptome, Metastasis and Chromosomal translocation. In his research on the topic of Neuroblastoma, Reprogramming and DNA methylation is strongly related with Epigenetics. The Cancer study combines topics in areas such as Disease and Oncology.
Olivier Delattre spends much of his time researching Cancer research, Sarcoma, Carcinogenesis, Transcription factor and Cancer. His Cancer research study combines topics in areas such as SMARCB1, Receptor, Neuroblastoma, Rhabdomyosarcoma and Pediatric cancer. His Sarcoma study combines topics from a wide range of disciplines, such as Gerontology, Chromosomal translocation, Transcriptome, Proto-Oncogene Protein c-fli-1 and Promoter.
His study in Transcription factor is interdisciplinary in nature, drawing from both Phenotype, Regulation of gene expression, Neuroscience and Cell biology. He has researched Cancer in several fields, including Disease, Cell growth and Oncology. His Somatic cell study contributes to a more complete understanding of Genetics.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Systematic identification of genomic markers of drug sensitivity in cancer cells
Mathew J. Garnett;Elena J. Edelman;Sonja J. Heidorn;Christopher Greenman;Christopher Greenman.
Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours
Olivier Delattre;Jessica Zucman;Béatrice Plougastel;Chantal Desmaze.
Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2
Guy A. Rouleau;Philippe Merel;Mohini Lutchman;Marc Sanson;Marc Sanson.
Truncating Mutations of hSNF5/INI1 in Aggressive Paediatric Cancer
Isabella Versteege;Nicolas Sévenet;Julian Lange;Marie-Françoise Rousseau-Merck.
The Ewing Family of Tumors -- A Subgroup of Small-Round-Cell Tumors Defined by Specific Chimeric Transcripts
O Delattre;J Zucman;T Melot;X S Garau.
The New England Journal of Medicine (1994)
Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas
Marcel Kool;Andrey Korshunov;Marc Remke;Marc Remke;David T.W. Jones.
Acta Neuropathologica (2012)
Valentina Boeva;Tatiana Popova;Kevin Bleakley;Pierre Chiche.
Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma
Isabelle Janoueix-Lerosey;Delphine Lequin;Delphine Lequin;Laurence Brugières;Agnès Ribeiro.
Subgroup-specific structural variation across 1,000 medulloblastoma genomes
Paul A. Northcott;Paul A. Northcott;David J.H. Shih;John Peacock;Livia Garzia.
Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome.
Yoon Jae Cho;Aviad Tsherniak;Pablo Tamayo;Sandro Santagata.
Journal of Clinical Oncology (2011)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: